Find and Pitch Jounalists, Get Your Story Covered

Tags: esketamine quetiapine remission depression depressive disorder

	Profile	Recent Articles on Subject
1	Kristen Monaco MedPage Today	Psychedelics for Psych Conditions Made Their Mark in 2023 - 5 months ago Another Mid-Stage Psychedelic Win; Gun Suicides Reach High; Magnetic Seizure Therapy - 6 months ago Psilocybin Shows Promise in Treatment-Resistant Bipolar Type II Depression - 6 months ago U.S. Suicides Hit Record High; FDA Reviews Schizophrenia Drug; Psychology of Misinfo - 6 months ago Positive KarXT Blood Pressure Data; ADHD Manufacturing Cover-Up? 'Profound Autism' - 6 months ago Schizophrenia Sexual Dysfunction; Nuplazid Box Warning Tweak; Psych Practice Fraud? - 8 months ago
2	Sophie Putka MedPage Today Enterprise, investigative writer. New York, USA enterprise journalisminvestigative journalism	Oral Factor XIa Inhibitor Disappoints for Secondary Stroke Prevention - 5 months ago
3	Gillian McGovern, Assistant Editor Pharmacy Times	FDA Approves Eplontersen for the Treatment of Adult Patients With ATTRv-PN - 5 months ago Quizartinib Plus Chemotherapy Improved OS in Patients with AML, Little Hindrance to QOL - 5 months ago FDA Approves Iptacopan for the Treatment of Paroxysmal Nocturnal Hemoglobinuria in Adult Patients - 6 months ago
4	Judy George MedPage Today	FDA Approves New Agent for Nerve Pain From Rare Inherited Disease - 5 months ago
5	Ionis Pharmafile	FDA approves AstraZeneca and Ionis’s Wainua - 5 months ago
6	AstraZeneca Pharmafile Covers pharma, biotech, healthcare. London, United Kingdom Pharmaceuticalsbiotechnologyhealthcare	FDA approves AstraZeneca and Ionis’s Wainua - 5 months ago
7	Damian Garde STAT News Biotech reporter at STAT. Open to messages. biotechnologyjournalism	STAT+: FDA approves AstraZeneca, Ionis treatment for rare nerve disease - 5 months ago STAT+: Pharmalittle: Texas sues Pfizer over ADHD drugs; Merck buys a neuro startup - 6 months ago
8	PT Staff Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Generic Product News: December 2023 - 5 months ago Subcutaneous Lecanemab Found Equally Effective as IV Version in Alzheimer Disease Treatment - 7 months ago
9	Emily Cooke Live Science	Widely used epilepsy drugs tied to rare, deadly side effect, FDA warns - 6 months ago
10	Nicoletta Lanese Live Science	Shroom compound psilocybin shows promise for bipolar disorder in early trial - 6 months ago

Journalists covering quetiapine